DiaMedica Therapeutics Inc.
DMAC
$3.53
-$0.01-0.28%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -25.92% | -22.56% | 0.62% | 0.19% | -15.43% |
| Total Depreciation and Amortization | 10.00% | 0.00% | 25.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 26.94% | 53.15% | -19.21% | 65.42% | 463.16% |
| Change in Net Operating Assets | -25.27% | 252.35% | 126.50% | -236.71% | 449.58% |
| Cash from Operations | -43.94% | 1.08% | 32.08% | -74.53% | 20.53% |
| Capital Expenditure | 22.22% | -- | 100.00% | -200.00% | 70.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 193.47% | -217.74% | 12.31% | -31.17% | 408.04% |
| Cash from Investing | 193.20% | -217.93% | 12.55% | -31.29% | 412.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -50.00% | -100.00% | 0.00% | 50.00% |
| Issuance of Common Stock | -2.38% | -98.93% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2.44% | -98.95% | 1,175,300.00% | 0.00% | 83.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 88.83% | -182.98% | 589.33% | -205.84% | 164.07% |